Modulation of human basophil migration in vitro by a soluble factor from virus-stimulated leukocytes

Michael A. Lett-Brown, John J. Hooks, Jerzy A. Georgides, David O. Thueson, J. Andrew Grant

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Although it is clear that respiratory virus infections frequently provoke attacks of asthma, the mechanism of the provocation is unknown. The accumulation of basophils in the sputum and the presence of basophil chemotactic factors in the serum of allergic patients suggests that the basophil may play a causative role in asthmatic attacks. We have investigated the effect of viruses on the in vitro migration of human basophils. When peripheral blood leukocytes from normal subjects were preincubated for 24 hr with uv-inactivated Sendai virus, the chemotactic response of basophils was augmented. This effect was also seen with the cell-free supernatant of mononuclear cells cultured with virus. Our results suggest that the soluble product mediating the enhancement is interferon. While the soluble factor enhanced basophil migration toward two chemoattractants (C5 peptide and a synthetic formyl-tripeptide), it has no effect on the migration of monocytes.

Original languageEnglish (US)
Pages (from-to)179-187
Number of pages9
JournalClinical Immunology and Immunopathology
Volume20
Issue number2
DOIs
StatePublished - 1981

Fingerprint

Basophils
Leukocytes
Viruses
Chemotactic Factors
Sendai virus
Virus Diseases
Sputum
Respiratory Tract Infections
Interferons
In Vitro Techniques
Monocytes
Cultured Cells
Asthma
Serum

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Pathology and Forensic Medicine

Cite this

Modulation of human basophil migration in vitro by a soluble factor from virus-stimulated leukocytes. / Lett-Brown, Michael A.; Hooks, John J.; Georgides, Jerzy A.; Thueson, David O.; Grant, J. Andrew.

In: Clinical Immunology and Immunopathology, Vol. 20, No. 2, 1981, p. 179-187.

Research output: Contribution to journalArticle

Lett-Brown, Michael A. ; Hooks, John J. ; Georgides, Jerzy A. ; Thueson, David O. ; Grant, J. Andrew. / Modulation of human basophil migration in vitro by a soluble factor from virus-stimulated leukocytes. In: Clinical Immunology and Immunopathology. 1981 ; Vol. 20, No. 2. pp. 179-187.
@article{cebc287824804fadb06bf5896168118d,
title = "Modulation of human basophil migration in vitro by a soluble factor from virus-stimulated leukocytes",
abstract = "Although it is clear that respiratory virus infections frequently provoke attacks of asthma, the mechanism of the provocation is unknown. The accumulation of basophils in the sputum and the presence of basophil chemotactic factors in the serum of allergic patients suggests that the basophil may play a causative role in asthmatic attacks. We have investigated the effect of viruses on the in vitro migration of human basophils. When peripheral blood leukocytes from normal subjects were preincubated for 24 hr with uv-inactivated Sendai virus, the chemotactic response of basophils was augmented. This effect was also seen with the cell-free supernatant of mononuclear cells cultured with virus. Our results suggest that the soluble product mediating the enhancement is interferon. While the soluble factor enhanced basophil migration toward two chemoattractants (C5 peptide and a synthetic formyl-tripeptide), it has no effect on the migration of monocytes.",
author = "Lett-Brown, {Michael A.} and Hooks, {John J.} and Georgides, {Jerzy A.} and Thueson, {David O.} and Grant, {J. Andrew}",
year = "1981",
doi = "10.1016/0090-1229(81)90176-8",
language = "English (US)",
volume = "20",
pages = "179--187",
journal = "Clinical Immunology",
issn = "1521-6616",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Modulation of human basophil migration in vitro by a soluble factor from virus-stimulated leukocytes

AU - Lett-Brown, Michael A.

AU - Hooks, John J.

AU - Georgides, Jerzy A.

AU - Thueson, David O.

AU - Grant, J. Andrew

PY - 1981

Y1 - 1981

N2 - Although it is clear that respiratory virus infections frequently provoke attacks of asthma, the mechanism of the provocation is unknown. The accumulation of basophils in the sputum and the presence of basophil chemotactic factors in the serum of allergic patients suggests that the basophil may play a causative role in asthmatic attacks. We have investigated the effect of viruses on the in vitro migration of human basophils. When peripheral blood leukocytes from normal subjects were preincubated for 24 hr with uv-inactivated Sendai virus, the chemotactic response of basophils was augmented. This effect was also seen with the cell-free supernatant of mononuclear cells cultured with virus. Our results suggest that the soluble product mediating the enhancement is interferon. While the soluble factor enhanced basophil migration toward two chemoattractants (C5 peptide and a synthetic formyl-tripeptide), it has no effect on the migration of monocytes.

AB - Although it is clear that respiratory virus infections frequently provoke attacks of asthma, the mechanism of the provocation is unknown. The accumulation of basophils in the sputum and the presence of basophil chemotactic factors in the serum of allergic patients suggests that the basophil may play a causative role in asthmatic attacks. We have investigated the effect of viruses on the in vitro migration of human basophils. When peripheral blood leukocytes from normal subjects were preincubated for 24 hr with uv-inactivated Sendai virus, the chemotactic response of basophils was augmented. This effect was also seen with the cell-free supernatant of mononuclear cells cultured with virus. Our results suggest that the soluble product mediating the enhancement is interferon. While the soluble factor enhanced basophil migration toward two chemoattractants (C5 peptide and a synthetic formyl-tripeptide), it has no effect on the migration of monocytes.

UR - http://www.scopus.com/inward/record.url?scp=0019427035&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019427035&partnerID=8YFLogxK

U2 - 10.1016/0090-1229(81)90176-8

DO - 10.1016/0090-1229(81)90176-8

M3 - Article

VL - 20

SP - 179

EP - 187

JO - Clinical Immunology

JF - Clinical Immunology

SN - 1521-6616

IS - 2

ER -